Chemically-Induced Disorders
7
2
4
2
Key Insights
Highlights
Success Rate
100% trial completion (above average)
Clinical Risk Assessment
Based on trial outcomes
Moderate Risk
Score: 40/100
0.0%
0 terminated out of 7 trials
100.0%
+13.5% vs benchmark
14%
1 trials in Phase 3/4
0%
0 of 2 completed with results
Key Signals
Data Visualizations
Phase Distribution
Trial Status
Trial Success Rate
Benchmark: 86.5%
Based on 2 completed trials
Clinical Trials (7)
Developing and Evaluating a Machine-Learning Opioid Overdose Prediction & Risk-Stratification Tool in Primary Care
Optimizing Chronic Pain Care With Mindfulness and Chronic Pain Management Visits
Study of the Safety and Feasibility of Psilocybin in Adults With Methamphetamine Use Disorder
GLP-1R Agonist Treatment for Opioid Use Disorder
An Open-Label Trial of Repetitive Transcranial Magnetic Stimulation for Opioid Use Disorder
Study of Structural Imaging
Neuroimmune Dysfunction in Alcohol Use Disorder